SCHEMBL19203546

SCHEMBL19203546

CC(C)(CCC(C)(C)c1cccc2cccnc12)c1ccc2cccnc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
LMNA P02545 3/20 0.39
HTT P42858 2/20 0.39
MEN1 O00255 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
NR4A2 P43354 1/20 0.39
CCR1 P32246 2/20 0.39
CCR5 P51681 2/20 0.39
CCR8 P51685 2/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP3A4 P08684 2/20 0.39
MAPT P10636 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
MMP2 P08253 2/20 0.39
TSHR P16473 2/20 0.39
GMNN O75496 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26033494 0.82 ALDH1A1 (0.47) ALDH1A1HTTMEN1CASP1CASP7
SCHEMBL22515591 0.79 OGA (0.40) ALDH1A1LMNAHTTMEN1CASP1
SCHEMBL20747972 0.77 AHR (0.43) ALDH1A1HTTMEN1CASP1CASP7
SCHEMBL21369323 0.77 KDM4E (0.45) ALDH1A1LMNAHTTCCR1CCR5
SCHEMBL14214637 0.77 ALDH1A1 (0.51) ALDH1A1LMNAHTTMEN1CASP1
SCHEMBL28818851 0.76 KDM4E (0.44) ALDH1A1LMNAHTTMEN1KMT2A
SCHEMBL18787930 0.75 CYP11B1 (0.43) ALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL1755723 0.74 KDM4E (0.47) ALDH1A1LMNAHTTMEN1KMT2A
SCHEMBL420840 0.73 ALDH1A1 (0.58) ALDH1A1LMNAHTTMEN1CASP1
SCHEMBL19170616 0.73 MEN1 (0.38) ALDH1A1LMNAHTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170218000-A1 PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS ARIAD PHARMACEUTICALS, INC. 2017-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170218000-A1 PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS MAP3K6, PIK3CA, MAP3K20 ALDH1A1 4677/4885LMNA 4121/4885HTT 4878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.